#75 Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
This commentary is clinically relevant because clinicians need current evidence on cannabis risks to properly counsel patients about adverse effects and make informed treatment recommendations. As new research emerges regularly on cannabis safety, regular reviews help practitioners stay current with evolving data that could affect patient care decisions and clinical guidance. Understanding documented harms allows clinicians to identify at-risk patients and discuss evidence-based alternatives or harm reduction strategies.
This commentary addresses emerging safety research on cannabis that clinicians should monitor regularly as new evidence accumulates. The author emphasizes that despite cannabis’s growing medical acceptance and legalization, periodic evaluation of potential harms remains essential for clinical practice. New research findings on cannabis dangers warrant ongoing review to ensure informed patient counseling and appropriate risk stratification in clinical decision-making. Healthcare providers should stay current with evolving evidence to accurately balance therapeutic potential against documented risks when considering cannabis in treatment plans. For clinicians, the practical takeaway is to regularly review updated cannabis safety literature and use evidence-based conversations with patients about both benefits and documented harms rather than relying on outdated assumptions.
“The evidence on cannabis harms has genuinely evolved over the past decade, and as clinicians we have an obligation to update our understanding rather than rely on outdated assumptions, but we also can’t treat every new study as a mandate to warn patients away from a medicine that demonstrably helps many of them manage pain, nausea, and anxiety when other options have failed or caused worse side effects.”
🏥 As cannabis legalization expands across jurisdictions, clinicians increasingly encounter patients using or considering cannabis for therapeutic purposes, making familiarity with emerging safety data essential for informed counseling. The frequent publication of new research on cannabis-related harms reflects both genuine scientific discovery and the historical knowledge gaps created by decades of restricted research, which complicates interpretation of individual studies and their clinical significance. Important confounders include the wide variability in cannabis potency, formulation, frequency of use, age of initiation, and individual genetic and psychiatric vulnerabilities, all of which influence risk profiles but are often incompletely characterized in population-based studies. Rather than dismissing cannabis or endorsing it uncritically, clinicians should maintain awareness of the evolving evidence base, particularly regarding neurodevelopmental effects in adolescents, psychotic disorders in vulnerable populations, and respiratory effects from smoking, while documenting these discussions in the medical record. A practical approach
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it: